GAS5 and breast cancer: High GAS5 expression is correlated with poor prognosis in BC, and GAS5 effectively inhibits EZH2 transcription by binding and recruiting E2F4 to EZH2 promoter region, to promote BC cell apoptosis (Wang et al., 2018c).